Dyadic International, Inc.
Dyadic International, Inc.
Dyadic International, Inc.
DYAI
DYAI
Nasdaq
Health Services
Medical/Nursing Services
1.19
USD
-0.02
-1.65%
Ditutup: 07-24 20:00 (UTC+0)
1.19
USD
+0.0559
+4.70%
Setelah jam pasar: 07-25 00:00 (UTC+0)

DYAI Statistik Utama

Tinggi
1.26
Buka
1.21
Volume
105.18K
Rendah
1.12
Cierre anterior
1.21
Nilai Perdagangan
125.54K
Tertinggi 52M
1.60
Volume relatif
0.371
Amplitudo (%)
11.49%
Terendah 52M
0.65
Tingkat Perputaran
0.29%
Kap Pasar
43.36M
P/E (TTM)
--
P/E (Tahunan)
--
P/B
-106.35
P/S
11.39
Laba per Saham (EPS)
-0.214
Dividen (TTM)
0
Imbal Hasil Dividen
0.00%
Saham beredar
36.43M
Mata uang
USD

DYAI Kinerja Harga

7 hari
30 hari
90 hari
180 hari
Sejak awal tahun
1 Tahun
DYAI Distribusi Arus Dana
DYAI Volume Short Sale Harian
DYAI Riwayat Short Interest
As of 2026-07-26, the Dyadic International, Inc. (DYAI) stock price today is 1.19. Based on this price, the company has a market capitalization of $43.36M, with a P/E ratio of --. On 2026-07-26, DYAI traded between 1.12 and 1.26. Today’s stock price is 6.25% above the daily low and 5.56% below the daily high, placing DYAI di sekitar bagian tengah de its most recent trading range. Trading volume currently stands at 105.18K, compared with an average daily volume of 283.91K. This suggests that trading activity is jauh di bawah level biasanya than usual. Over the past year, Dyadic International, Inc. shares have traded between 0.65 and 1.60. At today’s price, DYAI is 83.08% above its 52-week low and 25.63% below its 52-week high.
Nama Perusahaan
Dyadic International, Inc.
Sektor
Health Services
Industri
Medical/Nursing Services
Bursa
Nasdaq
Jumlah Karyawan
5
Ukuran Lot
100
Situs resmi
Mata uang
USD
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

DYAI FAQ

Cari
Lebih